Simulations Plus

Simulations Plus CapEx/OCF

Delisted·Oct 7, 2026

The CapEx to Operating Cash Flow Ratio of Simulations Plus (SLP) as of Nov 11, 2026 is 3.93 %. In the previous year, CapEx to Operating Cash Flow Ratio was 4.25 % — a change of -7.43% (lower).

CapEx/OCF

3.93 %

YoY

-7.43%

Last updated:

CapEx to Operating Cash Flow Ratio of Simulations Plus is 2025 3.93 % . CapEx to Operating Cash Flow Ratio of Simulations Plus was 2024 4.25 % . It decreases by -7.43% lower compared to the previous year.

The Simulations Plus CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
25.07 USD
Jan 1, 2019
16.80 USD
Jan 1, 2020
23.69 USD
Jan 1, 2021
23.83 USD
Jan 1, 2022
22.18 USD
Jan 1, 2023
19.55 USD
Jan 1, 2024
4.25 USD
Jan 1, 2025
3.93 USD
The Simulations Plus CapEx/OCF history
YEARCapEx/OCFYoY
3.93 %-7.43%
4.25 %-78.27%
19.55 %-11.85%
22.18 %-6.93%
23.83 %+0.61%
23.69 %+40.95%
16.80 %-32.98%
25.07 %+10.57%
22.68 %-0.56%
22.81 %+31.19%
17.38 %-76.31%
73.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

CapEx to Operating Cash Flow Ratio of Simulations Plus is 3.93 % in 2025.

CapEx to Operating Cash Flow Ratio of Simulations Plus changed from 4.25 % to 3.93 %, representing a -7.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Simulations Plus with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Simulations Plus

All Key Metrics — Simulations Plus